 |
|
|
 |
|
Health Care Agency
Public Health Services
Epidemiology & Assessment
(714) 834-8180
fax: (714) 834-8196
email: EPI@ochca.com
Health Referral Line
(800) 564-8448
(800) 801-7100 TDD
|
|
|
|
|
|
Rabies Postexposure Prophylaxis
Epidemiology & Assessment
For further information, visit the CDC rabies home page at: www.cdc.gov/ncidod/dvrd/rabies
|
Giving Rabies PEP
Because most physicians and nurses are not familiar
with rabies PEP, it is crucial to review the following
information prior to providing treatment. The three
components that are critical to rabies PEP are as
follows:
-
Immediate and thorough washing of the wound with soap and warm water
and irrigation with a
virucidal solution such as povidone-iodine solution.
-
Administration of Human Rabies Immune Globulin (HRIG)
HRIG is not indicated if the patient has had
pre-exposure prophylaxis or previous rabies PEP
treatment with currently licensed products. HRIG is given only once at the beginning of treatment. As
much of the HRIG as possible should be infiltrated into
and around the site of the wound(s). Any remaining HRIG should be injected IM into the gluteus
muscle. If there is not a visible wound present, and
there is no history of a percutaneous exposure, give the
HRIG as IM injection(s) into the gluteus muscle.
Although it is preferable to give HRIG at the time
of the first dose of vaccine, it can be given up to 7
days after starting the vaccine series. The dose is 20
IU/kg. It is supplied in a concentration of 150 IU/ml. To determine the dose, complete the following
calculations:
(Patient’s weight in pounds)
¸ (2.2 pounds/kg) = (Patient’s weight in kg) (Patient’s
weight in kg) x (20 IU/kg)
¸
(150 IU/ml) = dose of HRIG in ml
OR
(multiplying all the constants in the above equations)
(Patient’s weight in pounds)
x 0.06 = dose of HRIG in ml Example: A 150-pound person would require a dose of 9.1
ml. Please note: As the example
demonstrates, you will be giving a large number of ml’s.
There are two
licensed products available:
-
BayRabä,
Bayer Corporation, (800) 288-8370
-
Imogamâ
Rabies-HT, Aventis Pasteur, (800) 822-2463
As a reminder,
immunization with measles and rubella vaccines should not
be given until at least 3 months after receiving HRIG. Varicella vaccine should not be administered until at
least 4 months after receiving HRIG.
- Administration of Human Rabies Vaccine Series
The PEP vaccine series
consists of five 1.0-ml doses of vaccine given on days 0,
3, 7, 14, and 28. Give all doses of rabies vaccine IM in
the lateral deltoid in adults and in the anterolateral
aspect of the thigh for young children. Do not give
vaccine in the gluteus muscle.
If the patient had pre-exposure prophylaxis or previous
rabies PEP treatment with currently licensed products,
then only two doses of vaccine are given for PEP on days 0
and 3.
There are two rabies
vaccines licensed for use and currently available in the
United States:
-
Human Diploid Cell Vaccine (HDCV), trade name
Imovaxâ,
distributed by Aventis Pasteur Inc. (800) 822-2463
-
Purified Chick embryo Cell Culture (PCEC), trade
name RabAvertä,
distributed by Chiron Vaccines, (800) 244-7668 x 5812.
Please refer to the package inserts for warnings,
precautions, and adverse reactions. Please call
Epidemiology and Assessment at (714) 834-8180 for
assistance in assessing the risk of rabies and indications
for rabies PEP. All animal bites should be reported to
Animal Care Services at (714) 935-7419.
SUMMARY OF RABIES POST-EXPOSURE PROPHYLAXIS
|
|
No
history of pre- or post- exposure rabies immunization |
History of previous pre- or post- exposure rabies
immunization with currently licensed products |
|
HRIG
(BayRabä
or Imogamâ
Rabies-HT) |
-
Yes
-
Dose: 20 IU/kg
-
Dose calculation: (Patient’s weight in pounds) x
0.0606 = mls of HRIG
-
Infiltrate as much as possible into the wound site(s),
give the rest into the gluteal area
-
Give concurrently with first dose of vaccine if
possible but no later than 7 days after first dose
of vaccine.
|
None |
|
Vaccine
(Imovax®
Rabies*,or RabAvertä ) |
-
Five 1-ml doses given IM in the deltoid (anterolateral
thigh in young children).
-
Doses given on days 0, 3, 7, 14, and 28
|
-
Two
1-ml doses given IM in the deltoid (anterolateral
thigh in young children).
-
Doses given on days 0, 3
|
|
|
|
|